Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Classifica tra le azioni #30192
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Prezzo delle azioni
$0.22227521
Capitalizzazione di mercato
$17.81M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-14.81%
Paese
TW
Scambia TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Categoria

Cronologia dei frazionamenti azionari per TaiwanJ Pharmaceuticals Co., Ltd. (6549)
L’azione TaiwanJ Pharmaceuticals Co., Ltd. (simbolo: 6549) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 19, 2026.
Una quota di 6549 acquistata prima di Aug 19, 2026 equivale oggi a 0 quote di 6549.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE